Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$4.82M Buy
171,605
+89,120
+108% +$2.56M 0.08% 496
2017
Q3
$2.22M Sell
82,485
-330,341
-80% -$8.84M 0.04% 640
2017
Q2
$10.6M Buy
412,826
+199,655
+94% +$5.08M 0.23% 81
2017
Q1
$5.47M Buy
213,171
+186,317
+694% +$4.75M 0.12% 305
2016
Q4
$679K Buy
+26,854
New +$637K 0.02% 751
2015
Q1
Sell
-138,035
Closed -$3.65M 808
2014
Q4
$3.65M Buy
138,035
+58,641
+74% +$1.5M 0.19% 176
2014
Q3
$1.93M Buy
+79,394
New +$1.86M 0.15% 274

Other funds holding EXC

AHL Partners's EXC Position: Q4 2017 in Review

AHL Partners increased its Exelon (EXC) stake by 108% in Q4 2017, buying an estimated $2.56M and bringing the position to 171,605 shares worth $4.82M. The position accounts for 0.08% of the portfolio, ranked #496.

AHL Partners first reported a position in EXC in Q3 2014 and has held it in 7 quarters since. The position peaked at $10.6M in Q2 2017. 867 funds tracked by Wall St. Rank hold EXC as of Q4 2017.

  • AHL Partners held 171,605 shares of Exelon worth $4.82M as of Q4 2017.
  • AHL Partners bought 89,120 Exelon shares in Q4 2017, an estimated $2.56M.
  • Exelon made up 0.08% of AHL Partners's portfolio in Q4 2017, its #496 holding.
  • AHL Partners first reported a position in Exelon in Q3 2014 and has held it in 7 quarters since.
  • AHL Partners's Exelon position peaked at $10.6M in Q2 2017.
  • 867 funds tracked by Wall St. Rank held Exelon as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.